Reticulon 4 receptor

RTN4R
Identifiers
Aliases	RTN4R, NGR, NOGOR, Reticulon 4 receptor
External IDs	OMIM: 605566; MGI: 2136886; GeneCards: RTN4R
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 1OZN, 1P8T
Gene location (Human) Chr. Chromosome 22 (human) Band 22q11.21 Start 20,241,415 bp End 20,283,246 bp
Gene location (Mouse) Chr. Chromosome 16 (mouse) Band 16|16 A3 Start 17,945,506 bp End 17,970,272 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in right hemisphere of cerebellum testicle right frontal lobe Brodmann area 9 prefrontal cortex cingulate gyrus anterior cingulate cortex cerebellar vermis amygdala primary visual cortex Top expressed in primary visual cortex hippocampus proper Cortex of frontal lobe superior frontal gyrus dentate gyrus of hippocampal formation granule cell Anterior olfactory nucleus layer of neocortex cerebellar cortex secondary oocyte multiform layer of neocortex More reference expression data BioGPS n/a
Gene ontology Molecular function neuregulin receptor activity protein kinase inhibitor activity protein binding heparin binding chondroitin sulfate binding ganglioside GM1 binding ganglioside GT1b binding lipid binding signaling receptor activity protein-containing complex binding Cellular component cytoplasm membrane growth cone plasma membrane axonal growth cone integral component of plasma membrane soma endoplasmic reticulum anchored component of membrane neuron projection extracellular exosome cell surface anchored component of external side of plasma membrane dendritic shaft membrane raft axon dendrite cell projection perikaryon presynapse glutamatergic synapse Biological process negative regulation of protein kinase activity cytokine-mediated signaling pathway neuronal signal transduction positive regulation of GTPase activity negative regulation of axonogenesis negative regulation of axon extension negative regulation of receptor signaling pathway via JAK-STAT negative regulation of neuron projection development negative regulation of axon regeneration cell surface receptor signaling pathway axonogenesis corpus callosum development positive regulation of Rho protein signal transduction Sources:Amigo / QuickGO
Orthologs Databases NCBI: entry; OMA: entry Species Human Mouse Entrez 65078 65079 Ensembl ENSG00000040608 ENSMUSG00000043811 UniProt Q9BZR6 Q99PI8 RefSeq (mRNA) NM_023004 NM_022982 RefSeq (protein) NP_075380 NP_075358 Location (UCSC) Chr 22: 20.24 – 20.28 Mb Chr 16: 17.95 – 17.97 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Reticulon 4 receptor (RTN4R) also known as Nogo-66 Receptor (NgR) or Nogo receptor 1 is a protein which in humans is encoded by the RTN4R gene. This gene encodes the receptor for reticulon 4, oligodendrocytemyelin glycoprotein and myelin-associated glycoprotein. This receptor mediates axonal growth inhibition and may play a role in regulating axonal regeneration and plasticity in the adult central nervous system.

Function

The Nogo-66 Receptor (NgR) is a high affinity binding receptor for a region of Nogo, a myelin associated protein that inhibits axon outgrowth. NgR was identified by Strittmatter and colleagues using an expression cloning strategy.

NgR is implicated in neuronal plasticity and regeneration. Its relative importance in mediating myelin inhibition in vitro and in vivo is currently under intense investigation, since this protein might be a good drug target for treatment of various neurological conditions such as spinal cord injury and stroke.

Nogo pathway: rho kinase

While the entire pathway is not fully understood, the relationship between NgR and neuronal outgrowth has been fleshed out. NgR is a membrane protein that, when bound to neurite outgrowth inhibitor (Nogo), inhibits cell growth through the activation of rho kinase (ROCK).

NgR activation of p75

It was known that NgR, Nogo, and another membrane receptor called p75 were involved in inhibiting neurite outgrowth. Through a variety of experimental procedures Wang et al. were able to identify the biochemical relationship between NgR and p75. First, it was observed that when p75 was knocked out in mice, outgrowth inhibition was no longer seen. Completing binding assays and co-immunoprecipitations revealed that p75 and NgR were not bound to each other through the cellular membrane. Mutating either p75 or NgR, however, resulted in truncated protein that would help reveal the binding interactions. When the extracellular domains of the receptors were removed no outgrowth inhibition was seen. This would suggest that the receptors interact extracellularly. Furthermore, it was reaffirmed that Nogo and myelin-associated gylcoprotein (MAG) bind NgR and not p75. The receptor p75 lacks a binding domain for either of these proteins.

Activation of rho protein

The work of Kaplan and Miller shows that there is an interaction between the p75/NgR receptors and Rho GDP dissociation inhibitor (Rho-GDI). Kaplan and Miller show that when Nogo is bound to NgR, Rho-GDI is associated with p75. When Rho-GDI is drawn to p75 it is no longer bound to Rho-GDP. This allows for GTP to be exchanged for GDP activating the Rho protein. Rho-GTP, a Rho GTPase, then activates ROCK which phosphorylates other proteins which inhibit neurite outgrowth. When Nogo is not bound to NgR, p75 is not activated and Rho-GDI remains bound to Rho-GDP. The Rho protein remains bound with GDP and remains inactive. ROCK therefore does not become activated and cannot change transcription patterns to inhibit neuronal outgrowth.

Therapeutic inhibition

It is reasonable that inhibition of the above mechanism could aid the recovery of those suffering from spinal cord injuries. One such therapy is currently in clinical trials. The drug, called Cethrin, is produced by a group called Alseres. Cethrin is a ROCK inhibitor and therefore acts in the above pathway to prevent the activation of ROCK so neurite outgrowth can occur. Cethrin is applied as a paste to the site of injury during decompression surgery.

Regulation of visual cortex plasticity

The Nogo-66 receptor (NgR) limits experience-driven visual cortex plasticity. In mutant mice, non-functional NgR resulted in enhancement of visual cortex plasticity after the critical period into adulthood, such that adult plasticity in the mutant mice resembled normal visual plasticity in juvenile mice brains. This function of NgR is of particular interest to the study of visual disorders that may result from imbalanced input during the critical period, such as amblyopia.

See also

• Reticulon 4

Further reading

• Ng CE, Tang BL (2002). "Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration". Journal of Neuroscience Research. 67 (5): 559–565. doi:10.1002/jnr.10134. PMID 11891768.
• Ferraro GB (October 2007). "Refining our understanding of NgR1 function during myelin inhibition". The Journal of Neuroscience. 27 (43): 11451–11452. doi:10.1523/JNEUROSCI.3419-07.2007. PMC 6673219. PMID 17959786.
• Hartley JL, Temple GF, Brasch MA (2001). "DNA cloning using in vitro site-specific recombination". Genome Research. 10 (11): 1788–1795. doi:10.1101/gr.143000. PMC 310948. PMID 11076863.
• Wiemann S, Weil B, Wellenreuther R, Gassenhuber J, Glassl S, Ansorge W, et al. (March 2001). "Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs". Genome Research. 11 (3): 422–435. doi:10.1101/gr.GR1547R. PMC 311072. PMID 11230166.
• Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S (September 2000). "Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing". EMBO Reports. 1 (3): 287–292. doi:10.1093/embo-reports/kvd058. PMC 1083732. PMID 11256614.
• GrandPré T, Li S, Strittmatter SM (2002). "Nogo-66 receptor antagonist peptide promotes axonal regeneration". Nature. 417 (6888): 547–551. Bibcode:2002Natur.417..547G. doi:10.1038/417547a. PMID 12037567. S2CID 4414714.
• Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, et al. (June 2002). "Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth". Nature. 417 (6892): 941–944. Bibcode:2002Natur.417..941W. doi:10.1038/nature00867. PMID 12068310. S2CID 5734715.
• Liu BP, Fournier A, GrandPré T, Strittmatter SM (2002). "Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor". Science. 297 (5584). New York, N.Y.: 1190–1193. Bibcode:2002Sci...297.1190L. doi:10.1126/science.1073031. PMID 12089450. S2CID 1357777.
• Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, et al. (July 2002). "Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth". Neuron. 35 (2): 283–290. doi:10.1016/S0896-6273(02)00770-5. PMID 12160746.
• Woolf CJ, Bloechlinger S (2002). "Neuroscience. It takes more than two to Nogo". Science. 297 (5584). New York, N.Y.: 1132–1134. doi:10.1126/science.1076247. PMID 12183616. S2CID 31823737.
• Josephson A, Trifunovski A, Widmer HR, Widenfalk J, Olson L, Spenger C (November 2002). "Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans". The Journal of Comparative Neurology. 453 (3): 292–304. doi:10.1002/cne.10408. PMID 12378589. S2CID 44785423.
• He XL, Bazan JF, McDermott G, Park JB, Wang K, Tessier-Lavigne M, et al. (April 2003). "Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition". Neuron. 38 (2): 177–185. doi:10.1016/S0896-6273(03)00232-0. PMID 12718853.
• Barton WA, Liu BP, Tzvetkova D, Jeffrey PD, Fournier AE, Sah D, et al. (July 2003). "Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins". The EMBO Journal. 22 (13): 3291–3302. doi:10.1093/emboj/cdg325. PMC 165649. PMID 12839991.
• Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, et al. (October 2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Research. 13 (10): 2265–2270. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.